KELSEY TRULL: Open Payments
NPI 1508279043 · CONCORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 70 payments from 14 companies in 2025. Trend: 2023 $1,975 · 2024 $1,925 · 2025 $1,516
Food & beverage: $1,411Education: $105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $413 |
| Janssen Biotech, Inc. | 9 | $333 |
| Gilead Sciences, Inc. | 8 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $137 |
| Aimmune Therapeutics, Inc. | 4 | $107 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $77 |
| GENZYME CORPORATION | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $58 |
| Lilly USA, LLC | 2 | $47 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
Products named: TREMFYA, RINVOQ, CREON, ZENPEP, DUPIXENT, SKYRIZI, XIFAXAN, ENTYVIO.
Industry payments across NC — which companies pay providers there.
